TEST

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Others

RT-PCT Lab @ Purasawalkam
Loc

No.935, P.H.Road, Purasawalkam,
Chennai - 600084.
Loc

(Next to Blue Diamond Hotel)

9345612448, 9345650993
Loc

9345662303, 9345709039

Special On-Site services available for
factories and Companies. Contact :

Senthil : 8825611543
Loc

Yamini : 7397332352
Loc

Ganesan : 9840950389


User Name: Password: Forgot Password? Register here to avail member Exclusives Login Help

Test

Others

Note: Test Details are subject to change without any prior notice. Please confirm with the respective branches for current Details.


A	Top

Sno.	Test Name	Amount	Min Qty	Ref. Value
1	a -Lactalbumin (f 76) - SPECIFIC IgE	600		Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
2	A.S.O. TITRE	400	0.5 ml	Adults : upto 200 IU/ml Children : upto 150 IU/ml
3	A/G RATIO	120
4	ABDOMEN - ERECT VIEW (XRAY)	300
5	ABDOMEN (X -RAY)	300
6	ABDOMEN SCAN	750
7	ABSOLUTE B CELL COUNT	3500
8	ABSOLUTE BASOPHIL COUNT	100		0.0 - 100 cells/cmm
9	ABSOLUTE EOSINOPHIL COUNT	100	1 ml	100 - 400 cells/cmm
10	ABSOLUTE LYMPHOCYTE COUNT	100	2 ml	1550 - 4000 cells/cmm.
11	ABSOLUTE MONOCYTE COUNT	100		0.0 - 700 cells/cmm
12	ABSOLUTE NEUTROPHIL COUNT	100	2 ml	2500 - 7000 Cells/cmm
13	ACE ( ANGIO TENSIN CONVERTING ENZYME)	1500		8 - 52 U/L
14	Acetyl Choline Receptor Antibodies	4000		Normal Levels : 0.0 to 0.39 nMol/L Borderline Levels : 0.40 to 0.49 nMol/L Positive levels : More than 0.50 nMol/L Interpretation Acetyl choline receptor antibody (AchR) helps to diagnose Myasthenia gravis. AchR antibodies are not found in congenital Myasthenia gravis. Note: Laboratory reposts should not be interpreted in isolation. Always correlate with clinical and imaging data.
15	ACID PHOSPHATASE (PROSTATIC #)	500	1 ml	0 - 1.6 U/l
16	ACID PHOSPHATASE (TOTAL)	300	1 ml	Men : 0 - 4.7 U/l Women : 0 - 3.7 U/l
17	ACTH	1500	1 ml	7.2 - 63.3 pg/ml
18	ACTH STIMULATED 17 - OHP ( B)	900
19	ACTH - PM	1250		UP TO 46.0 pg/ml.
20	ACTH STIMULATED 17 OHP	1200		Males : 0.5 - 2.1 ng/ml Females Follicular Phase : 0.1 - 0.8 ng/ml Luteal Phase : 0.6 - 2.3 ng/ml Ovulation : 0.3 - 1.4 ng/ml Pregnancy 3rd Trimester : 2.0 - 12.0 ng/ml CHILDREN (Girls) 1 month after birth : 2.4 - 16.8 ng/ml 2 month after birth : 1.6 - 9.7 ng/ml 3 month after birth : 0.1 - 3.1 ng/ml CHILDREN (Boys) 1 month after birth : 0.0 - 8.0 ng/ml 2 month after birth : 3.6 - 13.7 ng/ml 3 month after birth : 1.7 - 4.0 ng/ml Post ACTH: <3.2 ng/ml Postmenopausal women: 0.13 - 0.51 ng/ml
21	ACTH STIMULATED CORTISOL	500
22	Activated Protein - C Resistance(APC - R)	3000	1 ml	More than 120 Seconds : Negative Less than 120 Seconds : Positive
23	Active-B12 ( Holo Trans Cobalamin)	1250		Normal Adults : 35.1 to 165.0 pmol/L Interpretation : Less than 35 : Deficient More than 35 : Not Deficient
24	ADENOSINE DEAMINASE (ADA) (ASCITIC FLUID)	750	2 ml	Normal : 0-30 U/L Positive : > 30 U/L ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and Malignancy.
25	ADENOSINE DEAMINASE (ADA) (ASPIRATION FLUID)	750
26	ADENOSINE DEAMINASE (ADA) (PERICARDIAL FLUID)	750	2 ML	Normal : < 30 U/L Suspect : 30 - 40 Strong suspect : 40 - 60 Positive : > 60 ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and Malignancy.
27	ADENOSINE DEAMINASE (ADA) (SYNOVIAL FLUID)	750
28	ADENOSINE DEAMINASE (ADA)(BRONCHIAL WASH)	750
29	ADENOSINE DEAMINASE (ADA)(CSF)	750		Normal : < 9 U/L Positive : > 9 U/L ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and Malignancy.
30	ADENOSINE DEAMINASE (ADA)(PERITONEAL FLUID)	750
31	ADENOSINE DEAMINASE (ADA)(PLEURAL FLUID)	750		Normal : 0-30 U/L Positive : > 30 U/L ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and Malignancy.
32	ADENOSINE DEAMINASE (ADA)(SERUM)	750	2 mL	Normal : 0-15 U/L Positive : > 15 U/L ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and Malignancy.
33	ADP	2000
34	AFB STAIN	250
35	AFB BACTEC ( MGIT) 460 - ISONIAZID (INH)	500
36	AFB BACTEC 460 - AMIKACIN	750
37	AFB BACTEC 460 - ETHAMBUTOL	750
38	AFB BACTEC 460 (MGIT) - SIREP	3000
39	AFB BACTEC 460 - CIPROFLOXACIN	750
40	AFB BACTEC 460 - CYCLOSERINE	750
41	AFB BACTEC 460 - ETHIONAMIDE	750
42	AFB BACTEC 460 - KANAMYCIN	750
43	AFB BACTEC 460 - OFLOXACIN	750
44	AFB BACTEC 460 - PAS	750
45	AFB BACTEC 460 - PYRAZINAMIDE	750
46	AFB BACTEC 460 - RIFAMPICIN	750
47	AFB BACTEC 460 - STREPTOMYCIN	750
48	AFB BACTEC 460 -GENTAMICIN	750
49	AFB BACTEC MGIT 320 - SIRE	3000
50	AFB CULTURE by BACTEC ( MGIT)-Other Specimens	1000
51	AFB CULTURE BY BACTEC( MGIT) Sputum	1000
52	AFB STAIN (ASPIRATED FLUID)	250
53	AFB STAIN (BRONCHIAL WASH)	200
54	AFB STAIN (CSF)	200
55	AFB STAIN (PERICARDIAL FLUID)	200
56	AFB STAIN - CONCENTRATED METHOD	150
57	AFP ( ASCITIC FLUID)	500	2 ML
58	AFP (ALPHA FETO PROTEINS)	600	1 ML	Normal Adults : 0.89- 8.78 ng/ml AFP (MATERNAL SERUM) Cut off 2.5 MoM 15 weeks : upto 32.17 ng/ml 80.44 16 weeks : upto 36.86 ng/ml 92.16 17 weeks : upto 42.24 ng/ml 105.6 18 weeks : upto 48.4 ng/ml 120.99 19 weeks : upto 55.45 ng/ml 138.63 20 weeks : upto 63.53 ng/ml 158.84 21 weeks : upto 72.80 ng/ml 181.99 AFP Levels Increased in : Cirrhosis Liver, Chronic Hepatitis, Neural Tube defects, Germ cell Tumours,and Hepatocellular carcinoma.(HCC)
59	AFP - (CSF)	500
60	AFP - Tumour Marker	600		Reference Value : 0 to 7.0 ng/ml. Increased in : Cirrhosis Liver, Chronic Hepatitis, Germ cell Tumours of the Ovary and Testis. Very High levels are found in Hepatocellular Carcinoma.
61	ALBERT S STAIN	200
62	ALBUMIN	100	0.5 ml	Children Upto 4days : 2.8 - 4.4 gm/dl 5 days -14 yrs : 3.8 - 5.4 gm/dl 15 Yrs -18 Yrs : 3.2 - 4.5 gm/dl Adults : 3.5 - 5.2 gm/dl.
63	ALBUMIN (ASCITIC FLUID)	100
64	ALBUMIN (CSF)	250		3 Months - 4 yrs : UPTO 45 mg/dl More than 4 yrs : 10- 30 mg/dl
65	ALBUMIN (PLEURAL FLUID)	100
66	ALCOHOL	200
67	Aldolase	1150		Up to 7.40 U/L Serum Aldolase determinations are useful in primary diseases of skeletal muscle. Aldolase activity is useful in distinguishing neuromuscular atrophies from myopathies when used in conjunction with CK levels. Serum Aldolase levels in the neonate is fourfold the adult activity and in children is twice that of adult values. Aldolase levels are also elevated in cases of muscle injury, gangrene or infection. Strenuous exercise temporarily increases aldolase values.
68	ALDOSTERONE	1750		ADULTS Supine : 30 -160 pg/ml Upright : 70 -300 pg/ml CHILDREN AT BIRTH : 300-1900 pg/ml 1 Month to 2 Yrs : 20 - 1100 pg/ml 3 Years to 16 Yrs: 12 - 340 pg/ml
69	Alere - Cardiac Panel	1200
70	Alere - D Dimer Test	900
71	Alere - ProfilEr SOB Panel	2000
72	Alere - Troponin I Test	750
73	ALK / EML 4 (NSCLC)	8000
74	ALKALINE PHOSPHATASE	150	0.5 ml	Children Male(U/L) Female(U/L) 0 - 14 Days 83- 248 83-248 15 Days - 1 Yr 122- 469 122-469 1 Yr - 10 Yrs 142- 335 142-335 10 Yrs - < 13Yrs 129- 417 129-417 13 Yrs - < 15Yrs 116- 468 57-254 15 Yrs - < 17Yrs 82- 331 50-117 17 Yrs - < 19Yrs 55- 149 45-87 ADULT MALES : 40-129 U/L ADULT FEMALES : 35-104 U/L
75	ALKAPTONURIA(URINE)	100
76	ALL SPERM	0		>=40
77	Almond ( f 20)- SPECIFIC IgE	600		Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
78	ALPHA 1 ANTI TRYPSIN	900	1 ML	90 - 200 mg/dl
79	Alpha Thalassemia MLPA	5500
80	Alpha Thalassemia Mutation Analysis	6000
81	Alternaria alternate (m6) - SPECIFIC IgE	600	1 ml	Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
82	ALUMINIUM	1500		40 �g/L or less
83	AMA-M2,LKM-1,SLA/LP and LC1.	4500		SLA/LP., LKM-1,LC-1 and AMA -M2 are done together in a single strip. It is not possible to do any of these tests alone. The charges for a single test or all the tests are the same. Hence all tests will be done and reported.
84	Amino Acid (Quantitative)	5500
85	Amino Acid ,Plasma	2250
86	Amino Acid Disorders by TMS	2000
87	AMINOACIDOGRAM	2200
88	AML Multiplex PCR Panel	7500
89	AMMONIA	600		Male : 16 - 60 �mol/L Female : 11 - 51 �mol/L
90	Amoxicillin ( c 204)- SPECIFIC IgE	600		Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
91	AMPHETAMINE (URINE)	200
92	AMYLASE (CYSTIC FLUID)	400
93	AMYLASE (URINE - 24 HOURS)	250		UPTO 1000 IU/L
94	AMYLASE -SERUM	400	1 ml	28-100 U/L
95	AMYLASE(ASCITIC FLUID)	400
96	AMYLASE(PANCREATIC FLUID)	400
97	AMYLASE(PERITONEAL FLUID)	400
98	AMYLASE(PLEURAL FLUID)	400
99	ANA / ENA EUROLINE	3000	1 ml
100	ANAEROBIC CULTURE	750
101	ANCA	2000	1 ml
102	ANDROSTENEDIONE	1000	1 ml	Females: 0 - 10 yrs : 0.02 - 0.86 ng/ml 11 - 17 yrs : 0.25 - 2.78 ng/ml 18 - 53 yrs : 0.75 - 3.89 ng/ml 54 - 82 yrs : 0.35 - 2.49 ng/ml Males: 0 - 10 yrs : 0.01 - 1.31 ng/ml 11 - 17 yrs : 0.33 - 3.30 ng/ml 18 - 53 yrs : 0.45 - 4.20 ng/ml 54 - 82 yrs : 0.30 - 3.93 ng/ml
103	ANKLE JOINT AP/LAT (LEFT)	300
104	ANKLE JOINT AP/LAT (RIGHT)	300
105	ANKLE JOINT AP/LAT/OBLIQUE (BOTH)	600
106	ANKLE JOINT AP/OBLIQUE (LEFT)	300
107	ANKLE JOINT AP/OBLIQUE (RIGHT)	300
108	ANTI - IA 2 Insulinoma Associated Antigen	5000		Less than 10.00 IU/mL Note: Negative results do not exclude the diagnosis of or future risk for type 1 diabetes mellitus.The risk of developing type 1 diabetes may be stratified further by testing for: 1) Insulin antibodies 2) GAD antibodies 3) HLA genetic markers
109	ANTI - RNP	1000		Less than 1.0 : Negative More than or equal to 1.0 TO 2.0: Weak Positive More than or equal to 2.0 TO 5.0: Positive More than or equal to 5.0 : High Positive
110	ANTI HB c (TOTAL)	600	1 ml
111	ANTI HBc IgM	600	1 ml
112	ANTI HBe	600	1 ml
113	ANTI HCV	750	1 ml	Interpretation : Sample RLU /Cut Off RLU Less than 1.0 Non Reactive More than 1.0 Reactive Reactive samples must be confirmed by HCV RNA. False Nonreactive results may occur during window period.Retesing should be done after 4 weeks.
114	ANTI HCV -ECLIA	600	1 ML
115	ANTI TB IGA (CSF)	300
116	ANTI TB IGG(CSF)	300
117	ANTI TB IGG(PLEURAL FLUID)	300
118	ANTI TB IGM (CSF)	300
119	ANTI TPO ANTIBODIES	750	0.5 ML	0.0 - 5.61 IU/ml.
120	ANTI - CCP	900		Less than 5.0 U/ml : Negative >(or)Equal to 5.0 U/ml : Positive Test methodology changed from CLIA to CMIA. Please note the change in reference interval.Result from different manufacturer cannot be used interchangeably.
121	ANTI CENTROMERE ANTIBODY	1000	1 ml	Less than 1.0 : Negative More than or equal to 1.0 TO 2.0: Weak Positive More than or equal to 2.0 TO 5.0: Positive More than or equal to 5.0 : High Positive
122	ANTI DNAse B (Anti Deoxyribo Nuclease B)	1500		Less than 200 U/ml This assay is used for demonstration of acute or recent streptococcal infection. A number of bacterial antigens have been identified in cultures of group A streptococci. These are primarily enzymatic proteins and include streptolysin O, streptokinase, hyaluronidase, deoxyribonucleases (DNases A, B, C, and D), and nicotinamide adenine nucleotidase. Infections by the group A streptococci are unique because they can be followed by the serious nonpurulent complications of Rheumatic fever and Glomerulonephritis.
123	ANTI GAD ANTIBODIES	2500		LESS THAN 10 IU/ml : NEGATIVE MORE THAN OR EQUAL TO 10 IU/mL: POSITIVE
124	Anti GBM Antibodies	1500		Reference Range : Intensity Class Result 0 - 5 0 NEGATIVE 6 - 10 (+) BORDERLINE 11 - 25 + WEAK POSITIVE 26 - 50 ++ POSITIVE > 50 +++ STRONG POSITVE NOTE: RESULTS IN THE BORDERLINE RANGE FROM 6 - 10 SHOULD BE EVALUATED AS INCREASED BUT NEGATIVE. PLEASE CORRELATE CLINICALLY
125	ANTI GBM ANTIBODY	1500	0.5 ml	Reference Range : Intensity Class Result 0 - 5 0 NEGATIVE 6 - 10 (+) BORDERLINE 11 - 25 + WEAK POSITIVE 26 - 50 ++ POSITIVE > 50 +++ STRONG POSITVE NOTE: RESULTS IN THE BORDERLINE RANGE FROM 6 - 10 SHOULD BE EVALUATED AS INCREASED BUT NEGATIVE. PLEASE CORRELATE CLINICALLY
126	Anti Gliadin Ab IgG	1200
127	Anti Gliadin IgA	1200
128	ANTI HAV IgG	600	1 ml	Less than 1.0 S/CO : Negative More than 1.0 S/CO : Positive
129	ANTI HAV IgM	600	1 ml
130	ANTI HBs (QUANTITATIVE)	600	0.5 ml	Less than 10 IU/l : No immunity More than 10 IU/l : Acquired immunity SUGGESTION FOR REVACCINATION :- Anti HBs Level REVACCINATION After Immunisation TO BE DONE Less than 10 IU/l - Immediately. 10 - 100 IU/l - After 3 - 6 months. 100 - 1000 IU/l - After One year 1000 - 10000 IU/l - After 3 - 5 Years More than 10000 IU/l - After 7 Years.
131	ANTI HEV IgM	750	1 ML
132	ANTI INSULIN ANTIBODY	3000		Less than 12 U/ml : Negative 12 - 18 U/ml : Equivocal More than 18 U/ml : Positive This is only a screening test for the diagnosis of IDDM (Type I Diabetes mellitus). It should be correlated with clinical history and results of other investigations. NOTE : 1. Predicting the future development of Type 1 Diabetes in asymptomatic children, adolescents and adults when used in conjunction with family history, HLA typing & other autoantibodies 2. Differential diagnosis of Type 1 versus Type 2 Diabetes 3. Evaluating diabetics with insulin resistance 4. Investigation of hypoglycemia in non-diabetic subjects
133	ANTI LKM 1 ANTIBODIES	800
134	ANTI MITOCHONDRIAL ANTIBODY	1000	0.5 ml
135	ANTI MULLERIAN HORMONE (AMH)	1350		Adult Females 20 - 24 yrs : 1.52 - 9.95 ng/ml 25 - 29 yrs : 1.20 - 9.05 ng/ml 30 - 34 yrs : 0.71 - 7.59 ng/ml 35 - 39 yrs : 0.40 - 6.96 ng/ml 40 - 44 yrs : 0.05 - 4.44 ng/ml 45 - 50 yrs : 0.01 - 1.79 ng/ml PCOS Women : 2.41 - 17.1 ng/ml Adult Males 1.43 -11.60 ng/ml
136	ANTI MUSK ANTIBODY	5000		LESS THAN 0.4 U/mL: NEGATIVE MORE THAN 0.4 U/ml: POSITIVE
137	ANTI NUCLEAR AB ( ANA/ ANF - BY IFA )	1000	0.5 ML
138	ANTI SMOOTH MUSCLE ANTIBODY	1000	1 ml
139	ANTI SPERM ANTIBODY	1200	0.5 ML	Less than 150 mU/100ul: Negative More than 150 mU/100ul: Positive
140	ANTI TB IGA	300	1 ml	Less than 300 U/ml: Negative 300 - 600 U/ml: Low Positive More than 600 U/ml: Positive
141	ANTI TB IGA (ASCITIC FLUID)	300
142	ANTI TB IGG	300	1 ml	Less than 400 U/ml : Negative 400 - 900 U/ml : Low Positive More than 900 U/ml : Positive
143	ANTI TB IGG (ASCITIC FLUID)	300
144	ANTI TB IGM	300	1 ml	Less than 0.8 units : Negative 0.8 - 1.0 units : Equivocal More than 1.0 units : Positive
145	ANTI TB IGM (ASCITIC FLUID)	300
146	ANTI TSH RECEPTOR ANTIBODY	2500	2 Ml	Upto 1.22 IU/L
147	Anti Xa, Heparin	6000		UFH Therapeutic Range : 0.30-0.70 IU/mL LMWH Therapeutic Ranges (target anti-Xa levels measured 4 hours after dosing): Enoxaparin (Lovenox) Therapeutic bid dosing : 0.6-1.0 IU/mL Therapeutic qD dosing : >1.0 IU/mL Tinzaparin (Innohep) Therapeutic qD : 0.85 IU/mL Dalteparin (Fragmin) Therapeutic qD : 1.05 IU/mL Reference : Chest 2012;141;e24s-e43s
148	Antidiuretic Hormone(ADH)	3500		30 - 150 pg/ml
149	ANTITHROMBIN III	1250	0.5 ML	80 - 120 %
150	APC-R ( Activated Protein C Resitance)	4000	1 ml	Clotting time of More than 120 Seconds reported as Negative , and less than 120 seconds reported as Positive. No time in seconds will be given in the report. APC-R positive patients may be referred for Factor V Leiden ( FVL) mutation Analysis to find out the Genotype.
151	APO LIPOPROTEIN A1	400	0.5 ml	12 - 19 Yrs Male : 99 - 165 mg/dl 12 - 19 Yrs Female: 105 - 180 mg/dl Normal risk Male : 104 - 202 mg/dl Normal risk Female: 108 - 225 mg/dl Favourable Male : > 202 mg/dl Favourable Female : > 225 mg/dl High Risk : < 104 mg/dl
152	APO LIPOPROTEIN E	500		3 - 6 mg/dl
153	APO LIPOPROTEIN B	400	0.5 ml	12 - 19 Yrs Male : 55 - 110 mg/dl 12 - 19 Yrs Female: 53 - 119 mg/dl Normal risk Male : 66 - 133 mg/dl Normal risk Female: 60 - 117 mg/dl High Risk Male : > 133 mg/dl High Risk Female : > 117 mg/dl Favourable : < 51 mg/dl
154	APPENDIX	500
155	Apple (f49) - SPECIFIC IgE	600		Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
156	APTT -Stago	250		Reference Range : 27 to 35 Seconds
157	Aquaporin & MOG ( Myeline Oligodendrocyte)	5000
158	Aquaporin & MOG ( Myeline Oligodendrocyte) CSF	5000
159	Aquaporin 4 Abs ( NMO Antibodies)	4000
160	Aquaporin 4 Abs( NMO Antibodies) -CSF	3000	1.5 ML CSF
161	ARSENIC	2000		0.4 - 11.9 ug/L
162	ASCA - IgA (Saccharomyces Ab IgA)	1250	1 mL	LESS THAN 12 U/ml: NEGATIVE 12 - 18 U/mL : EQUIVOCAL MORE THAN 18 U/mL: POSITIVE
163	ASCA - IgG (Saccharomyces Ab IgG)	1250	1 ml	LESS THAN 12 U/ml: NEGATIVE 12 - 18 U/mL : EQUIVOCAL MORE THAN 18 U/mL: POSITIVE
164	Aspergillosis Ab IgG - Serum	2000		Interpretation -------------- < 8.00 U/mL : Negative 8 - 12 U/mL : Equivocal > 12.00 U/mL : Positive Aspergillus organism has the ability to produce a wide spectrum of infections including Mycotoxicosis, allergic manifestations, localized non-invasive infection in normal host and invasive infection in the compromised host. Aspergillus fumigatus is the most common species associated with human diseases followed by Aspergillus flavus. Lung Aspergillosis includes Primary pulmonary aspergillosis, Acute invasive pulmonary disease, Aspergillus pseudotuberculosis, Chronic necrotizing pulmonary aspergillosis and Aspergilloma. All positive results should be confirmed by microbiologic and clinical evaluation. False positive results are commonly seen in children and in patients on antimicrobial therapy like Piperacillin -Tazobactum and Amoxicillin-Clavulanate.
165	Aspergillosis amstelodami(m17) - SPECIFIC IgE	600		Less than 0.35 IU/mL: Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL: Very High Positive
166	Aspergillosis fumigatus(m3) - SPECIFIC IgE	600	1 ml	Less than 0.35 IU/mL: Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL: Very High Positive
167	Aspergillus niger(m33) - SPECIFIC IgE	600		Less than 0.35 IU/mL: Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL: Very High Positive
168	Aspirin ( c 51)- SPECIFIC IgE	600		Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
169	Aspirin - Clopidogrel Resistance Test	3000		Interpretation : Clopidogrel Resistance Test: More than 46 : Resistance present. High Thrombotic Risk 31-19 : High Bleeding Risk Less than 19 : Very High Bleeding Risk. Dose may be reduced. Aspirin Resistance Test: 71- 115 : Resistance present Less than 40 : Inhibition of COX-1 by Aspirin. No resistance. Less than 30 : Strong inhibition of COX-1 by Aspirin. Dose may be reduced.
170	AUDIOMETRY	300
171	Autoimmune Encephalitis Panel(NMDA,AMPA,GABA,LG1,C	15000